cdmo.directory
← Compare landing

ProBioGen AG vs uBriGene

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/probiogen/ubrigene

CategoryProBioGen AGuBriGene
Listed sitecdmoboth
SummaryProBioGen is a fully integrated CDMO specializing in development and GMP manufacturing of therapeutic proteins, viral vectors, and vaccines, with proprietary platforms including CHO.RiGHT® for cell line development and AGE1.CR.pIX® for vaccine production.uBriGene is a global leader in advanced therapy medicinal products (ATMPs), cell and gene therapy CDMO services, and analytical testing. Headquartered in Maryland with operations across North America and Asia, the company specializes in bridging ATMP concepts from early…
Services
  • Analytical Method Development & Validation
  • ICH Stability Studies
  • EU EMA Regulatory Strategy
  • US FDA Regulatory Strategy
  • Analytical Method Development & Validation
  • US FDA Regulatory Strategy
  • EU EMA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Vaccine
  • AAV / Viral Vector Platform
  • mRNA
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
Indications
  • Oncology
  • Oncology
Locations
  • Headquarters, Berlin, Berlin, Germany
  • Office, Berlin, Berlin, Germany
  • Headquarters, Maryland, Maryland, USA
  • Boston, Boston, Massachusetts, USA
  • Worcester, Worcester, Massachusetts, USA
Certifications
  • EMA · Identifier: GMP compliant
  • FDA · Identifier: GMP compliant
  • FDA · Identifier: 20+ INDs filed and accepted
  • EMA · Identifier: 20+ INDs filed and accepted
  • NMPA · Identifier: 20+ INDs filed and accepted
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.